相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Association between glucose-lowering treatment and cancer metastasis among patients with preexisting type 2 diabetes and incident malignancy
Yoojin Noh et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
N-terminal degradation activates the NLRP1B inflammasome
Ashley J. Chui et al.
SCIENCE (2019)
Surface expression marker profile in colon cancer cell lines and sphere-derived cells suggests complexity in CD26+ cancer stem cells subsets
Lorena Vazquez-Iglesias et al.
BIOLOGY OPEN (2019)
Clinical Use of DPP-4 Inhibitors
Baptist Gallwitz
FRONTIERS IN ENDOCRINOLOGY (2019)
Magnolol Suppresses TGF-β-Induced Epithelial-to-Mesenchymal Transition in Human Colorectal Cancer Cells
Sungwoo Chei et al.
FRONTIERS IN ONCOLOGY (2019)
Linagliptin inhibits high glucose-induced transdifferentiation of hypertrophic scar-derived fibroblasts to myofibroblasts via IGF/Akt/mTOR signalling pathway
Yan Li et al.
EXPERIMENTAL DERMATOLOGY (2019)
A dipeptidyl peptidase-4 (DPP-4) inhibitor, linagliptin, attenuates cardiac dysfunction after myocardial infarction independently of DPP-4
Takehiro Yamaguchi et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2019)
Parthenolide inhibits transforming growth factor β1-induced epithelial-mesenchymal transition in colorectal cancer cells
Shi Mao Zhu et al.
INTESTINAL RESEARCH (2019)
Incretin-based Drugs and the Incidence of Colorectal Cancer in Patients with Type 2 Diabetes
Devin Abrahami et al.
EPIDEMIOLOGY (2018)
Significance of circulatory DPP4 activity in metabolic diseases
Titli Nargis et al.
IUBMB LIFE (2018)
Structures and mechanism of dipeptidyl peptidases 8 and 9, important players in cellular homeostasis and cancer
Breyan Ross et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Molecular Evidence of Adenosine Deaminase Linking Adenosine A2A Receptor and CD26 Proteins
Estefania Moreno et al.
FRONTIERS IN PHARMACOLOGY (2018)
Downregulating CD26/DPPIV by apigenin modulates the interplay between Akt and Snail/Slug signaling to restrain metastasis of lung cancer with multiple EGFR statuses
Jer-Hwa Chang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Emergence of CD26+Cancer Stem Cells with Metastatic Properties in Colorectal Carcinogenesis
Alvin Ho-Kwan Cheung et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Highly Sensitive Marker Panel for Guidance in Lung Cancer Rapid Diagnostic Units
Sonia Blanco-Prieto et al.
SCIENTIFIC REPORTS (2017)
Cardiovascular Actions and Clinical Outcomes With Glucagon-Like Peptide-1 Receptor Agonists and Dipeptidyl Peptidase-4 Inhibitors
Michael A. Nauck et al.
CIRCULATION (2017)
The regulatory role of DPP4 in atherosclerotic disease
Lihua Duan et al.
CARDIOVASCULAR DIABETOLOGY (2017)
First-in-human phase 1 of YS110, a monoclonal antibody directed against CD26 in advanced CD26-expressing cancers
Eric Angevin et al.
BRITISH JOURNAL OF CANCER (2017)
The dipeptidyl peptidase-4 inhibitor sitagliptin suppresses mouse colon tumorigenesis in type 2 diabetic mice
Naoki Yorifuji et al.
ONCOLOGY REPORTS (2016)
CD26/dipeptidylpeptidase IV-chemokine interactions: double-edged regulation of inflammation and tumor biology
Anneleen Mortier et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2016)
The front and rear of collective cell migration
Roberto Mayor et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2016)
DPPIV/CD26: a tumor suppressor or a marker of malignancy?
Aline Beckenkamp et al.
TUMOR BIOLOGY (2016)
Suppression of CD26 inhibits growth and metastasis of pancreatic cancer
Chunxiang Ye et al.
TUMOR BIOLOGY (2016)
Dipeptidyl peptidase 9 subcellular localization and a role in cell adhesion involving focal adhesion kinase and paxillin
Hui Zhang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2015)
CD26 a cancer stem cell marker and therapeutic target
Samuel Davies et al.
BIOMEDICINE & PHARMACOTHERAPY (2015)
Suppression of lung metastases by the CD26/DPP4 inhibitor Vildagliptin in mice
Jae-Hwi Jang et al.
CLINICAL & EXPERIMENTAL METASTASIS (2015)
Surgically resected human tumors reveal the biological significance of the gastric cancer stem cell markers CD44 and CD26
Shimpei Nishikawa et al.
ONCOLOGY LETTERS (2015)
Serum sCD26 for colorectal cancer screening in family-risk individuals: comparison with faecal immunochemical test
O. Otero-Estevez et al.
BRITISH JOURNAL OF CANCER (2015)
Dipeptidyl-Peptidase IV Activity Is Correlated with Colorectal Cancer Prognosis
Gorka Larrinaga et al.
PLOS ONE (2015)
Differential Expression and Enzymatic Activity of DPPIV/CD26 Affects Migration Ability of Cervical Carcinoma Cells
Aline Beckenkamp et al.
PLOS ONE (2015)
CD26-positive/CD326-negative circulating cancer cells as prognostic markers for colorectal cancer recurrence
Eva Lieto et al.
ONCOLOGY LETTERS (2015)
Dipeptidylpeptidase IV (CD26) defines leukemic stem cells (LSC) in chronic myeloid leukemia
Harald Herrmann et al.
BLOOD (2014)
Metastatic Stem Cells: Sources, Niches, and Vital Pathways
Thordur Oskarsson et al.
CELL STEM CELL (2014)
A high-throughput, multiplexed assay for superfamily-wide profiling of enzyme activity
Daniel A. Bachovchin et al.
NATURE CHEMICAL BIOLOGY (2014)
CD9 Negatively Regulates CD26 Expression and Inhibits CD26-Mediated Enhancement of Invasive Potential of Malignant Mesothelioma Cells
Toshihiro Okamoto et al.
PLOS ONE (2014)
Prognostic Significance of CD26 in Patients with Colorectal Cancer
Colin Siu-Chi Lam et al.
PLOS ONE (2014)
Postoperative Serum Levels of sCD26 for Surveillance in Colorectal Cancer Patients
Loretta De Chiara et al.
PLOS ONE (2014)
Evaluation of pleural effusion sCD26 and DPP-IV as diagnostic biomarkers in lung disease
Nuria Sanchez-Otero et al.
SCIENTIFIC REPORTS (2014)
Breast Cancer Stem Cells Transition between Epithelial and Mesenchymal States Reflective of their Normal Counterparts
Suling Liu et al.
STEM CELL REPORTS (2014)
Long-term treatment with Sitagliptin, a dipeptidyl peptidase-4 inhibitor, reduces colon carcinogenesis and reactive oxygen species in 1,2-dimethylhydrazine-induced rats
Angelo Pietro Femia et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Advances in Understanding the Expression and Function of Dipeptidyl Peptidase 8 and 9
Hui Zhang et al.
MOLECULAR CANCER RESEARCH (2013)
Epigenetic and genetic features of 24 colon cancer cell lines
D. Ahmed et al.
ONCOGENESIS (2013)
Serum activity of DPPIV and its expression on lymphocytes in patients with melanoma and in people with vitiligo
Ivana Z. Matic et al.
BMC IMMUNOLOGY (2012)
Comparative Clinical Pharmacokinetics of Dipeptidyl Peptidase-4 Inhibitors
Larry K. Golightly et al.
CLINICAL PHARMACOKINETICS (2012)
Colorectal Cancer Cells Activate Adjacent Fibroblasts Resulting in FGF1/FGFR3 Signaling and Increased Invasion
Maria L. Henriksson et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Identification of cancer stem cell markers in human malignant mesothelioma cells
Farhana Ishrat Ghani et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Serum DPPIV activity and CD26 expression on lymphocytes in patients with benign or malignant breast tumors
Aleksandra Eric-Nikolic et al.
IMMUNOBIOLOGY (2011)
Dipeptidyl Peptidases as Survival Factors in Ewing Sarcoma Family of Tumors IMPLICATIONS FOR TUMOR BIOLOGY AND THERAPY
Congyi Lu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Potential of soluble CD26 as a serum marker for colorectal cancer detection
Oscar J. Cordero et al.
WORLD JOURNAL OF CLINICAL ONCOLOGY (2011)
A Subpopulation of CD26+ Cancer Stem Cells with Metastatic Capacity in Human Colorectal Cancer
Roberta Pang et al.
CELL STEM CELL (2010)
On the origin of serum CD26 and its altered concentration in cancer patients
Oscar J. Cordero et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
CD26 inhibition and hematopoiesis: a novel approach to enhance transplantation
Timothy B. Campbell et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
Extraenzymatic functions of the dipeptidyl peptidase IV-related proteins DP8 and DP9 in cell adhesion, migration and apoptosis
Denise M. T. Yu et al.
FEBS JOURNAL (2006)
Stromal cell-derived factor-1α-induced cell proliferation and its possible regulation by CD26/dipeptidyl peptidase IV in endometrial adenocarcinoma
Y Mizokami et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Adenosine down-regulates the surface expression of dipeptidyl peptidase IV on HT-29 human colorectal carcinoma cells - Implications for cancer cell behavior
EY Tan et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Role for dipeptidyl peptidase IV in tumor suppression of human non small cell lung carcinoma cells
UV Wesley et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
A novel consensus motif in fibronectin mediates dipeptidyl peptidase IV adhesion and metastasis
HC Cheng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The multifunctional or moonlighting protein CD26/DPPIV
E Boonacker et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2003)
Involvement of dipeptidyl peptidase IV in extravillous trophoblast invasion and differentiation
Y Sato et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
Regulation of fibroblast migration on collagenous matrix by a cell surface peptidase complex
G Ghersi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
CD26: A multifunctional integral membrane and secreted protein of activated lymphocytes
MD Gorrell et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2001)